Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: Findings from the placebo arm of the International Breast Cancer Intervention Study I

Breast Cancer Research

Volumn 16, Issue 1, 2014, Pages

  Warwick, Jane ^a   Birke, Hanna ^b   Stone, Jennifer ^c   Warren, Ruth M L ^d   Pinney, Elizabeth ^b   Brentnall, Adam R ^b   Duffy, Stephen W ^b   Howell, Anthony ^e   Cuzick, Jack ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; BREAST CANCER; BREAST DENSITY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; TYRER CUZICK RISK SCORE; ABNORMALITIES; BREAST NEOPLASMS; MAMMARY GLAND; MULTICENTER STUDY (TOPIC); PATHOLOGY; RADIOGRAPHY; RISK FACTOR;

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; PLACEBO; TAMOXIFEN;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TAMOXIFEN;

EID: 84988892902     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-014-0451-5     Document Type: Article

References (21)

1. McCormack VA, Dos Santos SI: Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1159-1169.
2. Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M, Minkin S: Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:2086-2092.
3. Hutson SW, Cowen PN, Bird CC: Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol 1985, 38:281-287.
4. Baglietto L, Krishnan K, Stone J, Apicella C, Southey MC, English DR, Hopper JL, Giles GG: Associations of mammographic dense and nondense areas and body mass index with risk of breast cancer. Am J Epidemiol 2014, 179:475-483.
5. Assi V, Warwick J, Cuzick J, Duffy SW: Clinical and epidemiological issues in mammographic density. Nat Rev Clin Oncol 2012, 9:33-40.
6. Quante AS, Whittemore AS, Shriver T, Strauch K, Terry MB: Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance. Breast Cancer Res 2012, 14:R144.
7. Gail MH, Mai PL: Comparing breast cancer risk assessment models. J Natl Cancer Inst 2010, 102:605-608.
8. Tice JA, Cummings SR, Ziv E, Kerlikowske K: Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 2005, 94:115-122.
9. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K: Using clinical factors and mammographic density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008, 148:337-347.
10. Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-ErnstoffL, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K: Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006, 98:1204-1214.
11. Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, Benichou J, Gail MH: Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006, 98:1215-1226.
12. Cuzick J, Forbes J, Edwards R, Baum M, Cawthorn S, Coates A, Hamed A, Howell A, Powles T, IBIS investigators: First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 2002, 360:817-824.
13. Cuzick J, Forbes JF, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A, International Breast Cancer Intervention Study (IBIS) I Investigators: Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomised IBIS-I trial. J Natl Cancer Inst 2007, 99:272-282.
14. Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM: Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 2011, 103:744-752.
15. Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004, 23:1111-1130.
16. Pepe MS, Kerr KF, Longton G, Wang Z: Testing for improvement in prediction model performance. Stat Med 2013, 32:1467-1482.
17. Pencina MJ, D'Agostino RB, Steyerberg EW: Extension of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011, 30:11-21.
18. KrippendorffK: Bivariate agreement coefficients for reliability of data. In Sociological Methodology. Edited by Borgatta EF, Bohrnstedt GW. San Francisco: Jossey-Bass; 1970:139-150.
19. Lin LI: A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989, 45:255-268.
20. Evans DG, Warwick J, Astley SM, Stavrinos P, Sahin S, Ingham S, McBurney H, Eckersley B, Harvie M, Wilson M, Beetles U, Warren R, Hufton A, Sergeant JC, Newman WG, Buchan I, Cuzick J, Howell A: Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. Cancer Prev Res (Phila) 2012, 5:943-951.
21. Bondy ML, Newman LA: Assessing breast cancer risk: evolution of the Gail Model. J Natl Cancer Inst 2006, 98:1172-1173.